Panel members had questions about whether a new FDA proposal to require randomized trials for vaccines in healthy adults ...

The Food and Drug Administration has approved Moderna's new COVID-19 vaccine, days after the federal government tightened ...

The new vaccine is indicated for individuals who have been previously vaccinated with any COVID-19 vaccine and are 65 years or older, or 12 to 64 years of age with at least 1 underlying condition that ...

The FDA will require Moderna and Pfizer to add warnings to their COVID-19 vaccine labels about myocarditis and pericarditis in young men.

The FDA approved darolutamide (Nubeqa) for metastatic castration-sensitive prostate cancer (mCSPC). The agency previously ...

The shift indicates that critics' efforts to build support by releasing data on the harmful effects of the COVID-19 vaccines ...

The agency recommends manufacturers update their vaccines to target the JN.1 strain. At the same time, HHS head Robert F.

The FDA is also expanding its warning that some vaccines are linked to a risk of heart inflammation in young men.

Federal health officials have pulled back a key recommendation that pregnant women get the COVID-19 vaccine -- causing sharp ...

The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused ...

The shot is also cleared for individuals between 12 and 64 years of age who are at least one risk factor as defined by the ...

After a spring lull, experts are warning that cases will likely rise again ... Drugmaker Moderna announced that the FDA had approved its lower-dose COVID-19 vaccine for adults 65 and older, and people ...